Verona Pharma plc
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Verona Pharma plc
RECRUITINGPhase 2NCT07016412
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD
This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to placebo and to the individual...
Sponsor: Verona Pharma plcEnrolling: 48020 locations
Chronic Obstructive Pulmonary Disease
RECRUITINGPhase 2NCT06559150
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily...
Sponsor: Verona Pharma plcEnrolling: 18020 locations
Non-cystic Fibrosis Bronchiectasis